Drugs from the sea

Add to my library

BIO9200 V1 Article

Drugs from the sea

Author : Mehdi BENIDDIR

Publication date: October 10, 2017 | Lire en français

Add to my library Add to my library

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

Overview

ABSTRACT

The biodiversity of the marine environment together with its associated structurally diverse natural products have drawn the attention of research teams worldwide. Some 40 years of cumulative efforts have yielded six clinically useful approved drugs plus 30 agents in current clinical trials, from 25,000 discovered molecular entities. This article gives a current overview of marine-derived entities that have been EMA- and FDA-approved, their natural sources and their structural diversity. The main strategies used to overcome supply problems are also described.

Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.

Read the article

AUTHOR

  • Mehdi BENIDDIR : Senior Lecturer in Pharmacognosy BioCIS, Pharmacognosy-Chemistry of Natural Substances team, Faculty of Pharmacy, Châtenay-Malabry, Université Paris-Sud, Université Paris-Saclay, France

 INTRODUCTION

Natural substances from the plant kingdom and terrestrial micro-organisms (for example, morphine from poppies and penicillin G from the fungus Penicillium notatum) have long been considered the main source of active ingredients, for obvious reasons of ease of access and history of use. The considerable development of scuba diving since the end of the Second World War has enabled researchers to broaden their field of investigation to include an environment endowed with tremendous biodiversity. In addition to covering 71% of the earth's surface, the oceans alone are home to 34 of the 36 phyla that exist on planet Earth. The study of this biodiversity (red algae, sponges, ascidians and soft corals), which has mobilized a large number of academic and private research teams, has rapidly revealed an exceptional chemical diversity in terms of structural complexity (e.g. high degree of halogenation, high number of nitrogen atoms), with more than 25,000 chemical entities described today. Despite these numerous discoveries, obtaining sufficient quantities of an active compound - essential for validating the first preclinical studies - soon came up against problems posed by biological availability. To remedy this and succeed in developing drugs from the marine world, industrialists and academics had to redouble their ingenuity to cope with supply problems. These have included aquaculture, innovative chemical synthesis methodologies and bacterial fermentation. Today, the advent of the genomic era makes it possible to understand the conditions under which the molecule of interest is biosynthesized, and to characterize the actual producing organism, offering the prospect of industrially viable solutions to production problems.

After a brief description of the pharmaceutical portfolio related to marine-based medicines, this article details the various marine-based medicines currently used in therapeutics, as well as the – or – producing organization(s) (where these have been identified). Solutions deployed to overcome supply problems are also discussed.

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


KEYWORDS

Marine natural products   |   marine invertebrate   |   supply problem

Ongoing reading
Drugs from the sea

Article included in this offer

"Bioprocesses and bioproductions"

( 154 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details

Dans les ressources documentaires

Shampooings - Actifs adaptés à chaque problème spécifique

Dans cet article on s'intéresse aux ingrédients spécifiques retrouvés dans les shampooings traitants. Ces...

Nanotechnologies pour la thérapeutique et le diagnostic

L'adressage de molécules thérapeutiques vers l'organe, le tissu, ou la cellule malade constitue aujourd'h...

Chimie médicinale - Structure et activité du médicament

La chimie médicinale (ou thérapeutique) a pour but la découverte et la mise au point de nouveaux principe...

Chiralité et médicaments

Cet article a choisi de mettre en lumière l’importance de l’énantiométrie et de l’isomérie géométrique da...

WhitePaper
27 March 2015
Les bonnes pratiques de laboratoire

Les « bonnes pratiques de laboratoire », également appelées BPL, ont pour objectif d\'empêcher un nouveau scandale et sont appliquées au niveau mondial.

Tous les livres blancs
Article Le futur de la pharmacologie médicamenteuse
31 August 2023
Le futur de la pharmacologie médicamenteuse

Les principes actifs tirent leur origine du monde minéral, végétal ou animal, ou sont obtenus par voie synthétique, biologique ou biotechnologique. Les différen...

Toutes les actualités
Contact us